ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
AB Corporate Bond ETF

AB Corporate Bond ETF (EYEG)

35.74
0.00
( 0.00% )
Updated: 09:13:08

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
35.74
Bid
35.78
Ask
35.84
Volume
-
0.00 Day's Range 0.00
34.52 52 Week Range 37.24
Market Cap
Previous Close
35.74
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
567
Shares Outstanding
7,689,000
Dividend Yield
-
PE Ratio
-2.02
Earnings Per Share (EPS)
-1.7
Revenue
-
Net Profit
-13.05M

About AB Corporate Bond ETF

The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers m... The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers may include corporate or other business entities in which a sovereign or governmental agency or entity may have, indirectly or directly, an interest, including a majority or greater ownership interest. The Funds investment objective is to maximize total return through current income and longterm capital appreciation. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
AB Corporate Bond ETF is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EYEG. The last closing price for AB Corporate Bond ETF was US$35.74. Over the last year, AB Corporate Bond ETF shares have traded in a share price range of US$ 34.52 to US$ 37.24.

AB Corporate Bond ETF currently has 7,689,000 shares outstanding. The market capitalization of AB Corporate Bond ETF is US$274.80 million. AB Corporate Bond ETF has a price to earnings ratio (PE ratio) of -2.02.

EYEG Latest News

EyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York City

WALTHAM, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced that the Company will attend and present at the 21st...

EyeGate Pharmaceuticals Announces Meeting Date with FDA

WALTHAM, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today confirmed that it is scheduled to meet with the U.S. Food and...

EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced financial results for the three-month period ended...

EyeGate Pharma Announces Positive Results in Second PRK Study

Data confirms results from earlier study WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced top-line data from its study evaluating...

EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care

WALTHAM, Mass., Oct. 02, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules

WALTHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies

WALTHAM, Mass., Sept. 24, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Randomization of First Patients in Study for Punctate Epitheliopathies

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Top-Line Results for Phase 3 Trial of EGP-437 in Anterior Uveitis

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.04230.11849502909235.697735.81535.62135.6946SP
4-0.33-0.91488771832536.0736.1135.610735.93359081SP
12-0.865-2.3630651550336.60537.2435.656736.72064369SP
260.391.1032531824635.3537.2434.9158636.40076215SP
520.541.5340909090935.237.2434.5251935.88308469SP
1560.541.5340909090935.237.2434.5251935.88308469SP
2600.541.5340909090935.237.2434.5251935.88308469SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FLNTFlint Corporation
$ 0.035
(16.67%)
1,000
LEVLion Electric Company
$ 0.31
(14.81%)
548.81k
XLYAuxly Cannabis Group Inc
$ 0.04
(14.29%)
44.56k
AVLAvalon Advanced Materials Inc
$ 0.045
(12.50%)
19.63k
CFFConifex Timber Inc
$ 0.435
(11.54%)
15.5k
KLSKelso Technologies Inc
$ 0.115
(-20.69%)
22k
BUBurcon NutraScience Corporation
$ 0.125
(-19.35%)
376.76k
APLIAppili Therapeutics Inc
$ 0.03
(-14.29%)
9.1k
ARAAclara Resources Inc
$ 0.41
(-8.89%)
52.14k
CSCICOSCIENS Biopharma Inc
$ 3.83
(-8.81%)
4.9k
SLFSun Life Financial Inc
$ 85.40
(0.41%)
3.8M
BITFBitfarms Ltd
$ 2.88
(-4.95%)
2.77M
BTEBaytex Energy Corp
$ 4.29
(2.14%)
1.46M
BCEBCE Inc
$ 37.24
(-1.32%)
1.31M
SGNLSignal Gold Inc
$ 0.07
(0.00%)
1.02M

Discussion

View Full Feed
ORCA ORCA 3 minutes ago
SELL DAMMIT SELL.I WANT MY 20 MILLION SHARES BACK.SELL.
VDRM
chemist72 chemist72 3 minutes ago
Sitting by my desk watching our first snowfall of the season wondering if MVNT will ever have another trade. lol
MVNT
diamondguru-one diamondguru-one 3 minutes ago
learn how to read...............
GNCP
pennypop pennypop 3 minutes ago
I think I understand why this is taking so long. Go to Meta AI: type in corporations that Utilize RFE SVM and see what shows up. Then type in corporations within the military industrial complex that utilize RFE SVM and see what you get. This is not some low level algorithm. It’s Keystone. Big matzoh
SVM
pennypop pennypop 4 minutes ago
I think I understand why this is taking so long. Go to Meta AI: type in corporations that Utilize RFE SVM and see what shows up. Then type in corporations within the military industrial complex that utilize RFE SVM and see what you get. This is not some low level algorithm. It’s Keystone. Big matzoh
SVM
BBANBOB BBANBOB 4 minutes ago
TRUE DAT

Like I have stated before, I bought into DNDN at $9.30 watched it tick down for about a month to 6.35 and bailed, three weeks later it was 24$

And I swore I was NOT gonna do that here and have just continued to hold and buy more.........

Hope it
RDGL
Hawkeiz Hawkeiz 4 minutes ago
I agree something big coming 
SINC
Tootall7 Tootall7 4 minutes ago
Yeap they would not understand it.  I would like to vacation sometime in California maybe see Yosemite park and the redwoods
SPY
cableguy cableguy 4 minutes ago
Here we go again just busted over the 50 again, just would like to see it close there, LoL... VHAI
VHAI
ShawnP123 ShawnP123 4 minutes ago
I feel your assessment has been accurate as to the pricing on Nvidia shares. I have had my doubts about the price rolling into the last trading days of December. I don't and won't believe in 150-160. But now I'm even going to move out my first 6 month expectations to the mid second half of 2025. Rea
NVDA
Noghawbuck Noghawbuck 4 minutes ago
Ben’s the best guy for the job I can tell!
FUNN
gp22 gp22 4 minutes ago
$PDYN: AI Software for Robotics partner $RCAT CFO on Fox Business @ 10:40am est.....according to ST poster...Can NOT confirm
PDYN RCAT
tw0122 tw0122 4 minutes ago
.39-.40 up next then .46-.47 if it takes a few weeks chance to load more .30s
RNAZ
delerious1 delerious1 4 minutes ago
Clean Hydrogen Works Awards McDermott FEED Contract for Ascension Clean Energy (ACE) Project
November 21, 2024 07:00 AM Eastern Standard Time
THE WOODLANDS, Texas, & HOUSTON--(BUSINESS WIRE)--Clean Hydrogen Works (CHW) and McDermott announce that CHW has awarded McDermott the front-end
jobynimble jobynimble 4 minutes ago
SPAIF news yesterday…


Sparc AI Inc
Symbol SPAI
Shares Issued 13,044,316
Close 2024-11-20 C$ 0.21
Market Cap C$ 2,739,306
Recent Sedar Documents
View Original Document
Sparc AI talks software licensing


202
SPAI SPAIF
dinogreeves dinogreeves 5 minutes ago
SMCI is backlogged for the next five years. Bring on the audit, so we can move behind this fiasco, bring on Nasdaq extension so people can decide, bring on DOJ dismissal so the market can decide for themselves.
SMCI
snow snow 5 minutes ago
Guong If RD receives a lot of money as early as next week my view is that it is a very good time to invest if you pay 10 cents per share. But there is a real risk that he will not receive the money next week. He himself estimates that there is a 30% risk that he will not receive the money next week
HERB
Investor082 Investor082 5 minutes ago
Doesn’t take away the lies Dr. Zivic spewed. Besides he is not an oncologist. I trust the 70 odd neurologists/neurosurgeons on JAMA paper. However, they don’t go out and utter such non sense. These guys are reasonable and don’t BS like he has been doing over the years!
NWBO
JJZander JJZander 5 minutes ago
CEOS up on Elon tweet 
CEOS
walterc walterc 5 minutes ago
yes

well said and an excellent summary of the market dynamics in the sector.

Exactly how I understand it.
LWLG
getReady getReady 5 minutes ago
JB, we are now passed the five day late filing of the 10-Q. My thought here is we have another acquisition ready....

Failure to Meet the Form 10-Q Filing Deadline
When a company fails to file a 10-Q by the filing deadline, it must make a non-timely (NT) filing of SEC Form NT 10
ASII
Trooperstocks Trooperstocks 5 minutes ago
The Sustainable Green Team (SGTM) is leading the way in creating a greener future! From eco-conscious products to innovative sustainability practices, SGTM is proving that sustainability can drive both positive environmental impact and business success. 🌿

Their current lineup
SGTM
Cribbiobida Cribbiobida 5 minutes ago
So I thought I saw 2561 message from WestTexas indicating this is a dead horse. But why is it now gone?  Checked the Wyoming business site, no more updates on Groen there. 

Regardless, even if we are closing the book on this one, don't regret initial investment. Was an exciting ride,